| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 4.50e-10 | 9 | 29 | 4 | GO:0016308 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 5.25e-08 | 26 | 29 | 4 | GO:0052742 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 3.50e-07 | 41 | 29 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 2.04e-06 | 2 | 29 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.21e-06 | 18 | 29 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 6.10e-06 | 3 | 29 | 2 | GO:0000285 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-kinase activity | 6.10e-06 | 3 | 29 | 2 | GO:0052810 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.80e-06 | 28 | 29 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 2.03e-05 | 5 | 29 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.07e-05 | 37 | 29 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 4.09e-05 | 938 | 29 | 8 | GO:0016772 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 4.26e-05 | 7 | 29 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.41e-04 | 70 | 29 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | glucosidase activity | 2.11e-04 | 15 | 29 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 4.63e-04 | 709 | 29 | 6 | GO:0016773 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.57e-04 | 118 | 29 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | kinase activity | 6.87e-04 | 764 | 29 | 6 | GO:0016301 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 2.78e-03 | 54 | 29 | 2 | GO:0005246 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 2.14e-06 | 66 | 29 | 4 | GO:0046854 | |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 1.19e-05 | 217 | 29 | 5 | GO:0046474 | |
| GeneOntologyBiologicalProcess | regulation of Rab protein signal transduction | 2.85e-05 | 6 | 29 | 2 | GO:0032483 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | 3.28e-05 | 268 | 29 | 5 | GO:0008654 | |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | 3.28e-05 | 268 | 29 | 5 | GO:0045017 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 3.36e-05 | 132 | 29 | 4 | GO:0006661 | |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | 7.62e-05 | 320 | 29 | 5 | GO:0006650 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 9.01e-05 | 170 | 29 | 4 | GO:0046488 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 2.43e-04 | 410 | 29 | 5 | GO:0006644 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | 2.99e-04 | 429 | 29 | 5 | GO:0046486 | |
| GeneOntologyBiologicalProcess | mammary gland epithelial cell differentiation | 3.22e-04 | 19 | 29 | 2 | GO:0060644 | |
| GeneOntologyBiologicalProcess | Rab protein signal transduction | 3.94e-04 | 21 | 29 | 2 | GO:0032482 | |
| GeneOntologyCellularComponent | dynein complex | 6.30e-05 | 54 | 30 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | inner dynein arm | 8.90e-05 | 10 | 30 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | uropod | 1.79e-04 | 14 | 30 | 2 | GO:0001931 | |
| GeneOntologyCellularComponent | cell trailing edge | 2.07e-04 | 15 | 30 | 2 | GO:0031254 | |
| GeneOntologyCellularComponent | zymogen granule membrane | 3.72e-04 | 20 | 30 | 2 | GO:0042589 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.85e-04 | 25 | 30 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | zymogen granule | 9.61e-04 | 32 | 30 | 2 | GO:0042588 | |
| GeneOntologyCellularComponent | secretory granule membrane | 1.20e-03 | 329 | 30 | 4 | GO:0030667 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.56e-03 | 161 | 30 | 3 | GO:0005875 | |
| GeneOntologyCellularComponent | axoneme | 3.19e-03 | 207 | 30 | 3 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.23e-03 | 208 | 30 | 3 | GO:0097014 | |
| Domain | PInositol-4-P-5-kinase | 1.17e-07 | 7 | 29 | 3 | IPR023610 | |
| Domain | PIPK | 1.87e-07 | 8 | 29 | 3 | PS51455 | |
| Domain | PIPKc | 1.87e-07 | 8 | 29 | 3 | SM00330 | |
| Domain | - | 1.87e-07 | 8 | 29 | 3 | 3.30.800.10 | |
| Domain | PInositol-4-P-5-kinase_N | 1.87e-07 | 8 | 29 | 3 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 1.87e-07 | 8 | 29 | 3 | IPR027483 | |
| Domain | - | 1.87e-07 | 8 | 29 | 3 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 1.87e-07 | 8 | 29 | 3 | IPR002498 | |
| Domain | PIP5K | 1.87e-07 | 8 | 29 | 3 | PF01504 | |
| Domain | ATPase_dyneun-rel_AAA | 1.21e-06 | 14 | 29 | 3 | IPR011704 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.21e-06 | 14 | 29 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.21e-06 | 14 | 29 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.21e-06 | 14 | 29 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.21e-06 | 14 | 29 | 3 | PF08393 | |
| Domain | MT | 1.21e-06 | 14 | 29 | 3 | PF12777 | |
| Domain | AAA_8 | 1.21e-06 | 14 | 29 | 3 | PF12780 | |
| Domain | AAA_5 | 1.21e-06 | 14 | 29 | 3 | PF07728 | |
| Domain | DHC_fam | 1.51e-06 | 15 | 29 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.51e-06 | 15 | 29 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 1.51e-06 | 15 | 29 | 3 | PF03028 | |
| Domain | Pentatricopeptide_repeat | 5.84e-06 | 23 | 29 | 3 | IPR002885 | |
| Domain | MABP | 1.39e-05 | 4 | 29 | 2 | IPR023341 | |
| Domain | NtCtMGAM_N | 1.39e-05 | 4 | 29 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 1.39e-05 | 4 | 29 | 2 | IPR031727 | |
| Domain | MABP | 1.39e-05 | 4 | 29 | 2 | PS51498 | |
| Domain | Glyco_hydro_31_AS | 3.48e-05 | 6 | 29 | 2 | IPR030458 | |
| Domain | Glyco_hydro_31 | 4.87e-05 | 7 | 29 | 2 | PF01055 | |
| Domain | Glyco_hydro_31 | 4.87e-05 | 7 | 29 | 2 | IPR000322 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 4.87e-05 | 7 | 29 | 2 | PS00129 | |
| Domain | Trefoil | 6.48e-05 | 8 | 29 | 2 | PF00088 | |
| Domain | PPR | 6.48e-05 | 8 | 29 | 2 | PS51375 | |
| Domain | Dynein_heavy_dom-1 | 6.48e-05 | 8 | 29 | 2 | IPR013594 | |
| Domain | DHC_N1 | 6.48e-05 | 8 | 29 | 2 | PF08385 | |
| Domain | P_TREFOIL_2 | 8.32e-05 | 9 | 29 | 2 | PS51448 | |
| Domain | PD | 8.32e-05 | 9 | 29 | 2 | SM00018 | |
| Domain | - | 1.27e-04 | 11 | 29 | 2 | 4.10.110.10 | |
| Domain | P_trefoil_dom | 1.52e-04 | 12 | 29 | 2 | IPR000519 | |
| Domain | uDENN | 2.09e-04 | 14 | 29 | 2 | SM00800 | |
| Domain | Pept_M10A_Zn_BS | 2.41e-04 | 15 | 29 | 2 | IPR021158 | |
| Domain | uDENN | 2.41e-04 | 15 | 29 | 2 | PF03456 | |
| Domain | DENN | 2.76e-04 | 16 | 29 | 2 | PF02141 | |
| Domain | UDENN | 2.76e-04 | 16 | 29 | 2 | PS50946 | |
| Domain | DDENN | 2.76e-04 | 16 | 29 | 2 | PS50947 | |
| Domain | dDENN_dom | 2.76e-04 | 16 | 29 | 2 | IPR005112 | |
| Domain | uDENN_dom | 2.76e-04 | 16 | 29 | 2 | IPR005113 | |
| Domain | dDENN | 2.76e-04 | 16 | 29 | 2 | PF03455 | |
| Domain | DENN | 2.76e-04 | 16 | 29 | 2 | SM00799 | |
| Domain | DENN | 2.76e-04 | 16 | 29 | 2 | PS50211 | |
| Domain | DENN_dom | 2.76e-04 | 16 | 29 | 2 | IPR001194 | |
| Domain | dDENN | 2.76e-04 | 16 | 29 | 2 | SM00801 | |
| Domain | Gal_mutarotase_SF_dom | 3.12e-04 | 17 | 29 | 2 | IPR011013 | |
| Domain | Hemopexin_CS | 3.12e-04 | 17 | 29 | 2 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 3.51e-04 | 18 | 29 | 2 | IPR016293 | |
| Domain | PG_binding_1 | 4.35e-04 | 20 | 29 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 4.35e-04 | 20 | 29 | 2 | IPR002477 | |
| Domain | Hemopexin-like_dom | 5.77e-04 | 23 | 29 | 2 | IPR000585 | |
| Domain | Hemopexin | 5.77e-04 | 23 | 29 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 5.77e-04 | 23 | 29 | 2 | PS00024 | |
| Domain | - | 5.77e-04 | 23 | 29 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 5.77e-04 | 23 | 29 | 2 | PS51642 | |
| Domain | Hemopexin-like_repeat | 5.77e-04 | 23 | 29 | 2 | IPR018487 | |
| Domain | HX | 5.77e-04 | 23 | 29 | 2 | SM00120 | |
| Domain | Pept_M10A | 5.77e-04 | 23 | 29 | 2 | IPR021190 | |
| Domain | M10A_MMP | 5.77e-04 | 23 | 29 | 2 | IPR033739 | |
| Domain | Peptidase_M10 | 6.29e-04 | 24 | 29 | 2 | PF00413 | |
| Domain | ZnMc | 9.21e-04 | 29 | 29 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 9.21e-04 | 29 | 29 | 2 | IPR006026 | |
| Domain | Pkinase_C | 1.50e-03 | 37 | 29 | 2 | IPR017892 | |
| Domain | CYSTEINE_SWITCH | 1.84e-03 | 41 | 29 | 2 | PS00546 | |
| Domain | Pkinase_C | 1.93e-03 | 42 | 29 | 2 | PF00433 | |
| Domain | Pept_M10_metallopeptidase | 2.02e-03 | 43 | 29 | 2 | IPR001818 | |
| Domain | Glycoside_hydrolase_SF | 3.05e-03 | 53 | 29 | 2 | IPR017853 | |
| Domain | AGC-kinase_C | 3.40e-03 | 56 | 29 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.40e-03 | 56 | 29 | 2 | PS51285 | |
| Domain | S_TK_X | 3.40e-03 | 56 | 29 | 2 | SM00133 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.78e-05 | 27 | 27 | 3 | M47755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 7.35e-05 | 43 | 27 | 3 | M47669 | |
| Pathway | PID_RHOA_PATHWAY | 8.43e-05 | 45 | 27 | 3 | M12 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 8.43e-05 | 45 | 27 | 3 | M47670 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 9.00e-05 | 46 | 27 | 3 | M48317 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 1.09e-04 | 49 | 27 | 3 | M40046 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 1.16e-04 | 50 | 27 | 3 | MM14641 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.26e-04 | 9 | 27 | 2 | M47622 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 1.38e-04 | 53 | 27 | 3 | M662 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 1.46e-04 | 54 | 27 | 3 | M3896 | |
| Pathway | PID_RAC1_PATHWAY | 1.46e-04 | 54 | 27 | 3 | M278 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 4.01e-04 | 76 | 27 | 3 | M9052 | |
| Pathway | REACTOME_PI_METABOLISM | 4.17e-04 | 77 | 27 | 3 | MM14590 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 4.95e-04 | 196 | 27 | 4 | MM14591 | |
| Pathway | REACTOME_PI_METABOLISM | 5.38e-04 | 84 | 27 | 3 | M676 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 6.53e-04 | 211 | 27 | 4 | M649 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 6.57e-04 | 20 | 27 | 2 | MM1476 | |
| Pathway | BIOCARTA_RHO_PATHWAY | 7.25e-04 | 21 | 27 | 2 | M1001 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 7.95e-04 | 96 | 27 | 3 | M16121 | |
| Pathway | WP_B_CELL_RECEPTOR_SIGNALING | 8.19e-04 | 97 | 27 | 3 | M39323 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.69e-04 | 99 | 27 | 3 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.06e-03 | 106 | 27 | 3 | M27200 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.27e-03 | 113 | 27 | 3 | MM14783 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 1.39e-03 | 29 | 27 | 2 | MM15981 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.44e-03 | 118 | 27 | 3 | M713 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 1.49e-03 | 30 | 27 | 2 | M39652 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 2.86e-03 | 150 | 27 | 3 | M39520 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 2.97e-03 | 152 | 27 | 3 | MM15834 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 3.47e-03 | 46 | 27 | 2 | M46450 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 14681219 | ||
| Pubmed | PIP5KIβ selectively modulates apical endocytosis in polarized renal epithelial cells. | 5.79e-10 | 3 | 30 | 3 | 23342003 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 22942276 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 18188447 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 9535851 | ||
| Pubmed | Identification and characterization of a phosphoinositide phosphate kinase homolog. | 2.32e-09 | 4 | 30 | 3 | 14701839 | |
| Pubmed | The lipid kinase PIP5K1C regulates pain signaling and sensitization. | 5.78e-09 | 5 | 30 | 3 | 24853942 | |
| Pubmed | 7.26e-09 | 730 | 30 | 9 | 34857952 | ||
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 20841379 | ||
| Pubmed | Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. | 1.16e-08 | 6 | 30 | 3 | 14614850 | |
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 28581524 | ||
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 15018809 | ||
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 20622009 | ||
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 15046600 | ||
| Pubmed | 4.85e-08 | 9 | 30 | 3 | 22976293 | ||
| Pubmed | 2.09e-07 | 14 | 30 | 3 | 9373155 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8226919 | ||
| Pubmed | Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase. | 7.19e-07 | 2 | 30 | 2 | 8798574 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21270258 | ||
| Pubmed | PI4P5-kinase Ialpha is required for efficient HIV-1 entry and infection of T cells. | 7.19e-07 | 2 | 30 | 2 | 18981107 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15728183 | ||
| Pubmed | Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. | 7.19e-07 | 2 | 30 | 2 | 10187762 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19549683 | ||
| Pubmed | PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. | 7.19e-07 | 2 | 30 | 2 | 18073347 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12682053 | ||
| Pubmed | Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner. | 7.19e-07 | 2 | 30 | 2 | 23300084 | |
| Pubmed | Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking. | 7.19e-07 | 2 | 30 | 2 | 30789935 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28551623 | ||
| Pubmed | A role for PtdIns(4,5)P2 and PIP5Kalpha in regulating stress-induced apoptosis. | 7.19e-07 | 2 | 30 | 2 | 16979564 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 28958661 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34459757 | ||
| Pubmed | PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. | 7.19e-07 | 2 | 30 | 2 | 19889969 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32376619 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24834994 | ||
| Pubmed | Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. | 7.19e-07 | 2 | 30 | 2 | 19153220 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8955136 | ||
| Pubmed | Type Ialpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly. | 7.19e-07 | 2 | 30 | 2 | 10679324 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18772378 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21606841 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24360805 | ||
| Pubmed | MMP-1(-1607G) polymorphism as a risk factor for fibrosis after pulmonary tuberculosis in Taiwan. | 2.16e-06 | 3 | 30 | 2 | 20392358 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20160424 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 12906859 | ||
| Pubmed | Phosphatidylinositol 4-phosphate 5-kinase is indispensable for mouse spermatogenesis. | 2.16e-06 | 3 | 30 | 2 | 22321832 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 32650441 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19293200 | ||
| Pubmed | Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. | 2.16e-06 | 3 | 30 | 2 | 16311244 | |
| Pubmed | Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. | 2.16e-06 | 3 | 30 | 2 | 19321798 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 29458338 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 33902302 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 16676616 | ||
| Pubmed | CLIC1 recruits PIP5K1A/C to induce cell-matrix adhesions for tumor metastasis. | 2.16e-06 | 3 | 30 | 2 | 33079727 | |
| Pubmed | The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. | 2.16e-06 | 3 | 30 | 2 | 11875051 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18619044 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20078883 | ||
| Pubmed | Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. | 2.16e-06 | 3 | 30 | 2 | 18259971 | |
| Pubmed | Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer. | 4.31e-06 | 4 | 30 | 2 | 17000679 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 11546917 | ||
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 4.31e-06 | 4 | 30 | 2 | 18492703 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 23343931 | ||
| Pubmed | Molecular motors: the driving force behind mammalian left-right development. | 4.31e-06 | 4 | 30 | 2 | 10652513 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 22117411 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 19628284 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 21410539 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 19664242 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 9372970 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 29317790 | ||
| Pubmed | Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema. | 4.31e-06 | 4 | 30 | 2 | 23900981 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 22936257 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 20827277 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 17373931 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 31474569 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 26120586 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 24043512 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 19643940 | ||
| Pubmed | Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. | 1.08e-05 | 6 | 30 | 2 | 19132754 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 15123724 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 18006768 | ||
| Pubmed | Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. | 1.08e-05 | 6 | 30 | 2 | 17473191 | |
| Pubmed | Matrix metalloproteinase polymorphisms and bladder cancer risk. | 1.08e-05 | 6 | 30 | 2 | 17178858 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 28122331 | ||
| Pubmed | Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. | 1.51e-05 | 7 | 30 | 2 | 8921407 | |
| Pubmed | Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. | 1.51e-05 | 7 | 30 | 2 | 10859319 | |
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 11113146 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 17607721 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 9256245 | ||
| Pubmed | 3.22e-05 | 10 | 30 | 2 | 21098568 | ||
| Pubmed | 3.22e-05 | 10 | 30 | 2 | 23357697 | ||
| Pubmed | 3.94e-05 | 11 | 30 | 2 | 25283809 | ||
| Pubmed | Loss of ciliary transition zone protein TMEM107 leads to heterotaxy in mice. | 4.72e-05 | 12 | 30 | 2 | 31887266 | |
| Pubmed | 5.58e-05 | 13 | 30 | 2 | 12815621 | ||
| Pubmed | 5.58e-05 | 13 | 30 | 2 | 15944607 | ||
| Pubmed | 6.50e-05 | 14 | 30 | 2 | 16236725 | ||
| Pubmed | 8.57e-05 | 16 | 30 | 2 | 20484597 | ||
| Pubmed | 8.57e-05 | 16 | 30 | 2 | 37701782 | ||
| Pubmed | 1.35e-04 | 20 | 30 | 2 | 19590686 | ||
| Pubmed | 1.64e-04 | 22 | 30 | 2 | 10419448 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 1.64e-04 | 22 | 30 | 2 | 23421805 | |
| Pubmed | Atmin mediates kidney morphogenesis by modulating Wnt signaling. | 1.96e-04 | 24 | 30 | 2 | 24852369 | |
| Pubmed | Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms. | 2.13e-04 | 25 | 30 | 2 | 27340223 | |
| Interaction | PIP5KL1 interactions | 1.04e-07 | 7 | 30 | 3 | int:PIP5KL1 | |
| Interaction | PIP5K1B interactions | 8.43e-07 | 13 | 30 | 3 | int:PIP5K1B | |
| Interaction | PIP5K1A interactions | 3.18e-06 | 156 | 30 | 5 | int:PIP5K1A | |
| Interaction | PGBD5 interactions | 4.48e-05 | 7 | 30 | 2 | int:PGBD5 | |
| Interaction | PIP5K1C interactions | 5.57e-05 | 50 | 30 | 3 | int:PIP5K1C | |
| Interaction | MGAT5 interactions | 7.41e-05 | 55 | 30 | 3 | int:MGAT5 | |
| Interaction | HFM1 interactions | 7.66e-05 | 9 | 30 | 2 | int:HFM1 | |
| Interaction | MMP17 interactions | 9.57e-05 | 10 | 30 | 2 | int:MMP17 | |
| Interaction | SHISAL1 interactions | 9.62e-05 | 60 | 30 | 3 | int:SHISAL1 | |
| Interaction | PHRF1 interactions | 1.01e-04 | 61 | 30 | 3 | int:PHRF1 | |
| Interaction | MMP12 interactions | 1.17e-04 | 11 | 30 | 2 | int:MMP12 | |
| Interaction | SMURF1 interactions | 1.29e-04 | 544 | 30 | 6 | int:SMURF1 | |
| Interaction | PIP5K1P1 interactions | 1.40e-04 | 12 | 30 | 2 | int:PIP5K1P1 | |
| Interaction | PSMD8 interactions | 1.47e-04 | 182 | 30 | 4 | int:PSMD8 | |
| Cytoband | 11q22.3 | 3.84e-04 | 44 | 30 | 2 | 11q22.3 | |
| Cytoband | 4q12 | 6.00e-04 | 55 | 30 | 2 | 4q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q12 | 1.39e-03 | 84 | 30 | 2 | chr4q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.24e-03 | 107 | 30 | 2 | chr11q22 | |
| Cytoband | 7q34 | 5.35e-03 | 167 | 30 | 2 | 7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 6.52e-03 | 185 | 30 | 2 | chr7q34 | |
| GeneFamily | Dyneins, axonemal | 4.66e-07 | 17 | 17 | 3 | 536 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 2.27e-04 | 24 | 17 | 2 | 891 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.46e-04 | 25 | 17 | 2 | 504 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 184 | 30 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 184 | 30 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 184 | 30 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-08 | 169 | 30 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 183 | 30 | 4 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 151 | 30 | 3 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 151 | 30 | 3 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 154 | 30 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 154 | 30 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 154 | 30 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 154 | 30 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 155 | 30 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 155 | 30 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 167 | 30 | 3 | c2952d8ba763374c5678b92825c8956fc3e3ecd2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 169 | 30 | 3 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 169 | 30 | 3 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.32e-04 | 179 | 30 | 3 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-04 | 180 | 30 | 3 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 185 | 30 | 3 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 30 | 3 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 30 | 3 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 187 | 30 | 3 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 187 | 30 | 3 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.68e-04 | 188 | 30 | 3 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.77e-04 | 190 | 30 | 3 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 2.81e-04 | 191 | 30 | 3 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 2.81e-04 | 191 | 30 | 3 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.85e-04 | 192 | 30 | 3 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-04 | 196 | 30 | 3 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 3.12e-04 | 198 | 30 | 3 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-04 | 200 | 30 | 3 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| Drug | AC1L1IZE | 1.10e-08 | 131 | 28 | 6 | CID000004799 | |
| Drug | N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE | 1.46e-06 | 2 | 28 | 2 | DB07556 | |
| Drug | acetohydroxamic acid | 1.46e-05 | 5 | 28 | 2 | ctd:C006358 | |
| Drug | Biliton | 1.72e-05 | 41 | 28 | 3 | CID000002974 | |
| Drug | N-methylmesoporphyrin | 1.85e-05 | 42 | 28 | 3 | CID000444708 | |
| Drug | magnesium | 1.88e-05 | 1325 | 28 | 9 | CID000000888 | |
| Drug | mag-indo-1 | 3.05e-05 | 7 | 28 | 2 | CID000131881 | |
| Drug | vanadyl | 3.29e-05 | 307 | 28 | 5 | CID000061671 | |
| Drug | Marimastat | 4.07e-05 | 8 | 28 | 2 | DB00786 | |
| Drug | strychnine HCl | 6.81e-05 | 181 | 28 | 4 | CID000005304 | |
| Drug | A-C-A | 7.57e-05 | 67 | 28 | 3 | CID015955872 | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 4229_DN | |
| Drug | AC1L9NAZ | 9.65e-05 | 198 | 28 | 4 | CID000449606 | |
| Drug | C070379 | 9.84e-05 | 199 | 28 | 4 | CID003034747 | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; HL60; HT_HG-U133A | 9.84e-05 | 199 | 28 | 4 | 2487_DN | |
| Drug | ethosuximide | 1.02e-04 | 74 | 28 | 3 | CID000003291 | |
| Drug | AC1OAGGW | 1.06e-04 | 203 | 28 | 4 | CID006857364 | |
| Drug | NSC299933 | 1.13e-04 | 13 | 28 | 2 | CID000431902 | |
| Drug | pH Q | 1.24e-04 | 79 | 28 | 3 | CID000007708 | |
| Drug | Ageladine A | 1.32e-04 | 14 | 28 | 2 | ctd:C482289 | |
| Drug | nifedipine | 1.37e-04 | 415 | 28 | 5 | CID000004485 | |
| Drug | XeC compound | 1.48e-04 | 84 | 28 | 3 | CID000005701 | |
| Drug | tetradotoxin | 1.58e-04 | 428 | 28 | 5 | CID000020382 | |
| Drug | carbachol | 1.59e-04 | 688 | 28 | 6 | CID000002551 | |
| Drug | europium | 1.65e-04 | 87 | 28 | 3 | CID000023981 | |
| Drug | potassium | 1.71e-04 | 1008 | 28 | 7 | CID000000813 | |
| Drug | forskolin from Coleus forskohlii | 1.76e-04 | 1013 | 28 | 7 | CID000003413 | |
| Drug | MMI270 | 2.20e-04 | 18 | 28 | 2 | CID000446504 | |
| Drug | IC261 | 2.20e-04 | 96 | 28 | 3 | CID000003674 | |
| Drug | nitrendipine | 2.34e-04 | 98 | 28 | 3 | CID000004507 | |
| Drug | uranium | 2.43e-04 | 252 | 28 | 4 | CID000023989 | |
| Drug | AC1L380G | 2.46e-04 | 19 | 28 | 2 | CID000084698 | |
| Drug | aluminum citrate | 2.73e-04 | 20 | 28 | 2 | CID000091599 | |
| Drug | hydroxylysine | 3.20e-04 | 109 | 28 | 3 | CID000001029 | |
| Drug | DPCPX | 3.94e-04 | 117 | 28 | 3 | CID000001329 | |
| Drug | potassium cyanate | 3.96e-04 | 24 | 28 | 2 | CID011378442 | |
| Drug | ng h | 4.30e-04 | 25 | 28 | 2 | CID000448002 | |
| Drug | DA-125 | 4.65e-04 | 26 | 28 | 2 | CID000114758 | |
| Drug | CNQX | 4.90e-04 | 126 | 28 | 3 | CID000002821 | |
| Drug | 2-aminoethyl diphenylborinate | 5.01e-04 | 127 | 28 | 3 | CID000001598 | |
| Drug | benzylamide | 5.02e-04 | 27 | 28 | 2 | CID000010391 | |
| Drug | rhod-2 | 5.40e-04 | 28 | 28 | 2 | CID000123669 | |
| Drug | lanthanum | 6.12e-04 | 136 | 28 | 3 | CID000023926 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 6.21e-04 | 30 | 28 | 2 | CID000001226 | |
| Drug | Ataa | 6.21e-04 | 30 | 28 | 2 | CID000195836 | |
| Drug | mercuric acetate | 6.21e-04 | 30 | 28 | 2 | CID000015337 | |
| Drug | BAPTA | 6.29e-04 | 324 | 28 | 4 | CID000104751 | |
| Drug | Vgvapg | 6.63e-04 | 31 | 28 | 2 | CID000124934 | |
| Drug | malolactomycin D | 7.07e-04 | 32 | 28 | 2 | CID006449115 | |
| Drug | DE gel | 7.08e-04 | 143 | 28 | 3 | CID000008146 | |
| Drug | Dantrolene-13C3 | 7.37e-04 | 145 | 28 | 3 | CID000002951 | |
| Drug | nimodipine | 7.37e-04 | 145 | 28 | 3 | CID000004497 | |
| Drug | acetate | 7.38e-04 | 599 | 28 | 5 | CID000000175 | |
| Drug | macrocyclic inhibitor 4 | 7.52e-04 | 33 | 28 | 2 | CID016124959 | |
| Drug | AC1Q5UBL | 7.52e-04 | 146 | 28 | 3 | CID000005466 | |
| Drug | Bay K 8644 | 8.14e-04 | 150 | 28 | 3 | CID000002303 | |
| Drug | tyrphostin A1 | 8.46e-04 | 35 | 28 | 2 | CID000002063 | |
| Drug | sodium | 8.60e-04 | 944 | 28 | 6 | CID000000923 | |
| Drug | isoflavone | 8.95e-04 | 155 | 28 | 3 | CID000072304 | |
| Drug | 3-7a | 8.95e-04 | 36 | 28 | 2 | CID011987860 | |
| Drug | CaCl2 | 9.11e-04 | 156 | 28 | 3 | CID000024854 | |
| Drug | monomethyl phthalate | 9.24e-04 | 957 | 28 | 6 | ctd:C517284 | |
| Drug | Compound 10 | 9.46e-04 | 37 | 28 | 2 | CID003749170 | |
| Drug | mag-fura-2 | 9.46e-04 | 37 | 28 | 2 | CID000123839 | |
| Drug | benzyloxyaspartate | 9.46e-04 | 37 | 28 | 2 | CID004133412 | |
| Drug | gamma-Glu-Gly | 9.46e-04 | 37 | 28 | 2 | CID000100099 | |
| Drug | SAHA; Up 200; 10uM; PC3; HT_HG-U133A | 9.81e-04 | 160 | 28 | 3 | 1220_UP | |
| Drug | DMCM | 9.98e-04 | 38 | 28 | 2 | CID000104999 | |
| Drug | Ni-Fe active center | 1.05e-03 | 39 | 28 | 2 | CID005195770 | |
| Drug | cerium | 1.05e-03 | 39 | 28 | 2 | CID000008762 | |
| Drug | latanoprost acid | 1.11e-03 | 40 | 28 | 2 | CID006441636 | |
| Drug | epps | 1.11e-03 | 40 | 28 | 2 | CID000085255 | |
| Drug | AC1L9GJJ | 1.11e-03 | 40 | 28 | 2 | CID000444570 | |
| Drug | CGP55845 | 1.16e-03 | 41 | 28 | 2 | CID000123885 | |
| Drug | titanium | 1.17e-03 | 170 | 28 | 3 | CID000023963 | |
| Drug | Tetracycline | 1.20e-03 | 668 | 28 | 5 | ctd:D013752 | |
| Drug | AC1L1BV0 | 1.22e-03 | 42 | 28 | 2 | CID000001620 | |
| Disease | cancer (implicated_via_orthology) | 7.05e-06 | 268 | 30 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Barrett's esophagus (is_implicated_in) | 5.46e-05 | 11 | 30 | 2 | DOID:9206 (is_implicated_in) | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 6.55e-05 | 12 | 30 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 9.02e-05 | 14 | 30 | 2 | DOID:14004 (is_marker_for) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 2.07e-04 | 21 | 30 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Pigmented Basal Cell Carcinoma | 3.72e-04 | 28 | 30 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 3.99e-04 | 29 | 30 | 2 | C4721806 | |
| Disease | 1,5 anhydroglucitol measurement | 3.99e-04 | 29 | 30 | 2 | EFO_0008009 | |
| Disease | arteriosclerosis (is_implicated_in) | 4.56e-04 | 31 | 30 | 2 | DOID:2349 (is_implicated_in) | |
| Disease | Primary ciliary dyskinesia | 6.16e-04 | 36 | 30 | 2 | cv:C0008780 | |
| Disease | Primary Ciliary Dyskinesia | 1.05e-03 | 47 | 30 | 2 | C4551720 | |
| Disease | interleukin 1 receptor antagonist measurement | 1.33e-03 | 53 | 30 | 2 | EFO_0004754 | |
| Disease | brain measurement, neuroimaging measurement | 2.23e-03 | 550 | 30 | 4 | EFO_0004346, EFO_0004464 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.73e-03 | 276 | 30 | 3 | EFO_0004612, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TNFKLIYRYAFDFAR | 191 | Q92564 | |
| SRYDYFARTVPPDFF | 176 | Q14416 | |
| EYLETKRIAFPRFYF | 1616 | Q96DT5 | |
| YSPIFYVAFFKGRFV | 636 | Q9NQ90 | |
| FFDAFRKFLTFLYRY | 321 | Q7Z401 | |
| DAAVFNPRFYRTYFF | 381 | P39900 | |
| YRAYVAFPDFFRNST | 1331 | Q2M2H8 | |
| YEFTFRRFFDDNGYP | 1076 | O95835 | |
| YRAYVAFPDFFRNST | 1376 | O43451 | |
| LYRAYVAFPDFFRNS | 2271 | O43451 | |
| FRFKTYAPLAFRYFR | 81 | O14986 | |
| SKYIRPRIQYFFSFA | 306 | O60669 | |
| DFRFKTYAPVAFRYF | 136 | Q99755 | |
| YNAFRFKTYAPVAFR | 81 | A2A3N6 | |
| FRSIFKEFPYFNYIQ | 271 | A2PYH4 | |
| EYLETKRSAFPRFYF | 1316 | Q9P2D7 | |
| AFPAFRAFLTFLYRY | 326 | O75064 | |
| SARIQRTVFVFYYFF | 131 | Q86UP6 | |
| DYLDSKRNAFPRFFF | 1556 | Q8IVF4 | |
| FVFRRYAEFDKLYNT | 46 | Q96BR1 | |
| PSFLRFQLDFYQVYF | 36 | Q6N075 | |
| FVRSFKYFYGLRFEV | 66 | O15120 | |
| FFKDRFYMRTNPFYP | 296 | P03956 | |
| FRFKTYAPVAFRYFR | 131 | O60331 | |
| REYDFIAAQFKYFSF | 786 | Q13635 | |
| VDRGFFRSVFYRSYK | 801 | P30876 | |
| RSDSSFRFFVFFFVY | 211 | O15126 | |
| VYLYTVVAFNFFRKF | 4681 | Q15413 | |
| YKFRVDFTEALYPAF | 601 | Q14258 | |
| PNYKSFRFYRFALKE | 2251 | O15050 | |
| REDYIYGFQFKAFHF | 126 | Q13508 |